Pf679 real-world safety data from a noninterventional long-term postauthorization safety study of ruxolitinib in myelofibrosisF. Barraco,R. Greil,R. Herbrecht, H. Burkhard Schmidt,A. Reiter, W. Willenbacher,R. Raymakers, R. Liersch, M. Wroclawska,R. Pack, K. Burock, M. Levine, H. GisslingerHemaSphere(2019)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要